"Designing Growth Strategies is in our DNA"

Australia Equine Health Market Size, Share & Industry Analysis, By Product (Drugs {Anti-Infectives, Anti-Inflammatory, Parasiticides, Others}, Vaccines {Inactivated, Live Attenuated, Recombinant, Others}, Supplemental Feed Additives), By Disease (West Nile Virus, Equine Rabies, Equine Influenza, Equine Herpes Virus, Potomac Horse Fever, Tetanus, Others), By Distribution Channel (Veterinary Hospitals and Clinics, Retail Pharmacies & Drug Stores, Others), and Regional Forecast, 2025-2032

Last Updated: December 15, 2025 | Format: PDF | Report ID: FBI113858

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year 

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 5.8% from 2025-2032

Unit

Value (USD million)

Segmentation

By Product

  • Drugs
    • Anti-Infectives
    • Anti-Inflammatory
    • Parasiticides
    • Others
  • Vaccines
    • Inactivated
    • Live Attenuated
    • Recombinant
    • Others
  • Supplemental Feed Additives

By Disease

  • West Nile Virus
  • Equine Rabies
  • Equine Influenza
  • Equine Herpes Virus
  • Potomac Horse Fever
  • Tetanus
  • Others

By Distribution Channel

  • Veterinary Hospitals and Clinics
  • Retail Pharmacies & Drug Stores
  • Others

 

Australia Equine Health Market
  • 2019-2032
  • 2024
  • 2019-2023
  • 102
  • Buy Now

    (Offer valid till 15th Jan 2026)

Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports